This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
McEwan P, Mehin N, Tetlow AP, Sharplin P.The relative cost effectiveness of switching to insulin glargine versus NPH insulin in insulin naive and non insulin naive Type 2 diabetes patients using UK real life data. Value in Health 10: A223, No. 6, Nov-Dec 2007
About this article
Cite this article
Insulin glargine better value than NPH in T2DM. Pharmacoecon. Outcomes News 541, 8 (2007). https://doi.org/10.2165/00151234-200705410-00010
- Discrete Event
- Insulin Glargine
- Health Utility
- Discrete Event Simulation
- Lifetime Cost